Ettorre VM, Bellone S, Greenman M, McNamara B, et al. A phase 2 trial of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability (NCT02899793): Updated survival and response analyses. Gynecol Oncol 2025;197:110-115.
PMID: 40334308